Souvie Biodelivery
Pre-clinicalSouvie Biodelivery is focused on developing engineered exosomes for tissue and site specific active pharmaceutical ingredient (API) delivery. Our solution has the potential to increase biocompatibility, non-immunogenicity, and API protection to eliminate API degradation, while also increasing specificity and efficacy to virtually eliminate adverse drug reactions.
About
Souvie Biodelivery is focused on developing engineered exosomes for tissue and site specific active pharmaceutical ingredient (API) delivery. Our solution has the potential to increase biocompatibility, non-immunogenicity, and API protection to eliminate API degradation, while also increasing specificity and efficacy to virtually eliminate adverse drug reactions.
Company Info
Contact
Sectors
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile